Physician profile
Ashley B Benson
NPI 1265488191
$2,335.80
in general payments reported to CMS, 2019-2025
32 companies · $557 in 2025
The $557 reported for 2025 was more than what 83% of Obstetrics providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $409 · 2020: $64.85 · 2021: $169 · 2022: $432 · 2023: $396 · 2024: $309 · 2025: $557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,261.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $403.11 | 2019-2023 | Lo Loestrin Fe, Orilissa, Oriahnn |
| Astellas Pharma US INC | $293.58 | 2019-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $170.80 | 2022-2025 | |
| Channel Medsystems, INC. | $169.17 | 2022-2023 | |
| Pfizer INC. | $143.07 | 2019-2025 | |
| Exeltis, USA INC. | $123.07 | 2021-2025 | Slynd |
| Amgen INC. | $110.19 | 2019-2024 | Prolia, Evenity |
| Mayne Pharma Commercial LLC | $90.64 | 2025 | |
| Daiichi Sankyo INC. | $72.05 | 2019-2022 | |
| Organon LLC | $70.14 | 2024-2025 | Nexplanon |
| Therapeuticsmd, INC. | $68.67 | 2019-2022 | |
| Optumhealth Care Solutions, LLC | $59.77 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Sage Therapeutics, LLC | $53.39 | 2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $43.48 | 2024 | Myfembree |
| Avion Pharmaceuticals | $40.00 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $39.50 | 2025 | Qelbree |
| Millicent US INC | $35.56 | 2025 | Intrarosa, Femring, Femlyv |
| Scynexis, INC. | $34.78 | 2022 | |
| Covidien LP | $32.45 | 2019-2020 | |
| Aspira Women'S Health INC | $29.48 | 2023 | Ova1 |
| Ethicon US, LLC | $29.15 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $26.28 | 2022 | |
| Lupin INC. | $25.62 | 2019 | |
| Amag Pharmaceuticals, INC. | $25.27 | 2019 | |
| Roche Diagnostics Corporation | $22.36 | 2019 | |
| Myovant Sciences INC. | $21.91 | 2022 | |
| Stryker Corporation | $20.55 | 2025 | Triton Canister System |
| Coopersurgical, INC. | $18.69 | 2025 | Paragard T 380a |
| Agile Therapeutics, INC. | $17.64 | 2021 | |
| Smith+Nephew, INC. | $17.32 | 2024 | Pico |
| Hologic Sales and Service, LLC | $16.58 | 2024 | Novasure, Myosure Tissue Removal Device |
| Merck Sharp & Dohme LLC | $11.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Benson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.